ArticleScientific reports2019

Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion.

Yasutaka Murahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.